New drug aims to boost survival in severe pneumonia patients on ventilators
Disease control
Recruiting now
This study tests whether adding trimodulin to standard care helps adults with severe community-acquired pneumonia who need a breathing machine. About 590 hospitalized patients will receive either trimodulin or a placebo. The main goal is to see if more patients survive at least 2…
Phase: PHASE3 • Sponsor: Biotest • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC